These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 28192494
21. Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization. Souto EB, Müller RH. J Microencapsul; 2006 Jun; 23(4):377-88. PubMed ID: 16854814 [Abstract] [Full Text] [Related]
22. Physicochemical characteristics, cytotoxicity, and antioxidant activity of three lipid nanoparticulate formulations of alpha-lipoic acid. Ruktanonchai U, Bejrapha P, Sakulkhu U, Opanasopit P, Bunyapraphatsara N, Junyaprasert V, Puttipipatkhachorn S. AAPS PharmSciTech; 2009 Jun; 10(1):227-34. PubMed ID: 19280350 [Abstract] [Full Text] [Related]
23. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity. Baig MS, Ahad A, Aslam M, Imam SS, Aqil M, Ali A. Int J Biol Macromol; 2016 Apr; 85():258-70. PubMed ID: 26740466 [Abstract] [Full Text] [Related]
24. A novel approach based on lipid nanoparticles (SLN) for topical delivery of alpha-lipoic acid. Souto EB, Müller RH, Gohla S. J Microencapsul; 2005 Sep; 22(6):581-92. PubMed ID: 16401575 [Abstract] [Full Text] [Related]
25. Modification of oral absorption of oxyresveratrol using lipid based nanoparticles. Sangsen Y, Wiwattanawongsa K, Likhitwitayawuid K, Sritularak B, Wiwattanapatapee R. Colloids Surf B Biointerfaces; 2015 Jul 01; 131():182-90. PubMed ID: 25988282 [Abstract] [Full Text] [Related]
26. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Das S, Ng WK, Tan RB. Eur J Pharm Sci; 2012 Aug 30; 47(1):139-51. PubMed ID: 22664358 [Abstract] [Full Text] [Related]
27. Effect of drug solubility and lipid carrier on drug release from lipid nanoparticles for dermal delivery. Zoubari G, Staufenbiel S, Volz P, Alexiev U, Bodmeier R. Eur J Pharm Biopharm; 2017 Jan 30; 110():39-46. PubMed ID: 27810471 [Abstract] [Full Text] [Related]
28. Antimicrobial activity of polymyxin-loaded solid lipid nanoparticles (PLX-SLN): Characterization of physicochemical properties and in vitro efficacy. Severino P, Silveira EF, Loureiro K, Chaud MV, Antonini D, Lancellotti M, Sarmento VH, da Silva CF, Santana MHA, Souto EB. Eur J Pharm Sci; 2017 Aug 30; 106():177-184. PubMed ID: 28576561 [Abstract] [Full Text] [Related]
29. Delivery of retinoic acid to LNCap human prostate cancer cells using solid lipid nanoparticles. Akanda MH, Rai R, Slipper IJ, Chowdhry BZ, Lamprou D, Getti G, Douroumis D. Int J Pharm; 2015 Sep 30; 493(1-2):161-71. PubMed ID: 26200751 [Abstract] [Full Text] [Related]
30. α-Tocopherol succinate improves encapsulation and anticancer activity of doxorubicin loaded in solid lipid nanoparticles. Oliveira MS, Mussi SV, Gomes DA, Yoshida MI, Frezard F, Carregal VM, Ferreira LAM. Colloids Surf B Biointerfaces; 2016 Apr 01; 140():246-253. PubMed ID: 26764108 [Abstract] [Full Text] [Related]
31. Solvent injection-lyophilization of tert-butyl alcohol/water cosolvent systems for the preparation of drug-loaded solid lipid nanoparticles. Wang T, Wang N, Zhang Y, Shen W, Gao X, Li T. Colloids Surf B Biointerfaces; 2010 Aug 01; 79(1):254-61. PubMed ID: 20447810 [Abstract] [Full Text] [Related]
32. Mucoadhesive chitosan-coated PLGA nanoparticles for oral delivery of ferulic acid. Lima IA, Khalil NM, Tominaga TT, Lechanteur A, Sarmento B, Mainardes RM. Artif Cells Nanomed Biotechnol; 2018 Aug 01; 46(sup2):993-1002. PubMed ID: 29842790 [Abstract] [Full Text] [Related]
33. FA-loaded lipid drug delivery systems: preparation, characterization and biological studies. Carbone C, Campisi A, Musumeci T, Raciti G, Bonfanti R, Puglisi G. Eur J Pharm Sci; 2014 Feb 14; 52():12-20. PubMed ID: 24514450 [Abstract] [Full Text] [Related]
34. Physicochemical properties of lipid nanoparticles: effect of lipid and surfactant composition. Martins S, Tho I, Ferreira DC, Souto EB, Brandl M. Drug Dev Ind Pharm; 2011 Jul 14; 37(7):815-24. PubMed ID: 21214488 [Abstract] [Full Text] [Related]
35. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance. Mitri K, Shegokar R, Gohla S, Anselmi C, Müller RH. Int J Pharm; 2011 Jul 29; 414(1-2):267-75. PubMed ID: 21596122 [Abstract] [Full Text] [Related]
36. Preparation and cytotoxicity of 2-methoxyestradiol-loaded solid lipid nanoparticles. Guo X, Xing Y, Mei Q, Zhang H, Zhang Z, Cui F. Anticancer Drugs; 2012 Feb 29; 23(2):185-90. PubMed ID: 22027535 [Abstract] [Full Text] [Related]
37. Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles. Silva AC, Kumar A, Wild W, Ferreira D, Santos D, Forbes B. Int J Pharm; 2012 Oct 15; 436(1-2):798-805. PubMed ID: 22867992 [Abstract] [Full Text] [Related]
38. SLN for topical application in skin diseases--characterization of drug-carrier and carrier-target interactions. Küchler S, Herrmann W, Panek-Minkin G, Blaschke T, Zoschke C, Kramer KD, Bittl R, Schäfer-Korting M. Int J Pharm; 2010 May 10; 390(2):225-33. PubMed ID: 20153414 [Abstract] [Full Text] [Related]
39. SLN and NLC for topical delivery of ketoconazole. Souto EB, Müller RH. J Microencapsul; 2005 Aug 10; 22(5):501-10. PubMed ID: 16361193 [Abstract] [Full Text] [Related]
40. Rifabutin-loaded solid lipid nanoparticles for inhaled antitubercular therapy: Physicochemical and in vitro studies. Gaspar DP, Faria V, Gonçalves LM, Taboada P, Remuñán-López C, Almeida AJ. Int J Pharm; 2016 Jan 30; 497(1-2):199-209. PubMed ID: 26656946 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]